• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因突变在急性早幼粒细胞白血病中的影响:一项荟萃分析

The Impact of Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis.

作者信息

Picharski Gledson L, Andrade Diancarlos P, Fabro Ana Luiza M R, Lenzi Luana, Tonin Fernanda S, Ribeiro Raul C, Figueiredo Bonald C

机构信息

Instituto de Pesquisa Pelé Pequeno Príncipe, 1532 Silva Jardim, AV., Curitiba, Paraná 80250-200, Brazil.

Faculdades Pequeno Príncipe, 333 Iguaçu Av., Rebouças, Curitiba, Paraná 80230-902, Brazil.

出版信息

Cancers (Basel). 2019 Sep 5;11(9):1311. doi: 10.3390/cancers11091311.

DOI:10.3390/cancers11091311
PMID:31492033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6770268/
Abstract

The association of mutations with white blood cell (WBC) counts at diagnosis and early death was studied in patients with acute promyelocytic leukemia (APL). Publications indexed in databases of biomedical literature were analyzed. Potential publication bias was evaluated by analyzing the standard error in funnel plots using the estimated relative risk (RR). Mixed-effect models were used to obtain the consolidated RR. All analyses were conducted using the R statistical software package. We used 24 publications in the final meta-analysis. Of 1005 males and 1376 females included in these 24 publications, 645 had -ITD (internal tandem duplication) mutations. Information on -D835 mutations was available in 10 publications for 175 patients. Concurrent occurrence of the two mutations was rare. WBC count at diagnosis was ≥10 × 10/L in 351 patients. For patients with the -ITD mutation, RR was 0.59 for overall survival (OS) and 1.62 for death during induction. For those with -D835 mutations, the RR was 0.50 for OS and 1.77 for death during induction. RR for WBC count ≥10 × 10/L was 3.29 and 1.48 for patients with -ITD and -D835, respectively. APL patients with -ITD or -D835 are more likely to present with elevated WBC counts and poorer prognosis than those without these mutations.

摘要

在急性早幼粒细胞白血病(APL)患者中,研究了突变与诊断时白细胞(WBC)计数及早期死亡之间的关联。对生物医学文献数据库中索引的出版物进行了分析。通过使用估计的相对风险(RR)分析漏斗图中的标准误差来评估潜在的发表偏倚。采用混合效应模型获得合并RR。所有分析均使用R统计软件包进行。最终的荟萃分析中我们使用了24篇出版物。在这24篇出版物纳入的1005名男性和1376名女性中,645人有内部串联重复(-ITD)突变。在10篇出版物中有175名患者的-D835突变信息。两种突变同时出现的情况很少见。351名患者诊断时的白细胞计数≥10×10⁹/L。对于有-ITD突变的患者,总生存期(OS)的RR为0.59,诱导期死亡的RR为1.62。对于有-D835突变的患者,OS的RR为0.50,诱导期死亡的RR为1.77。有-ITD和-D835突变的APL患者比没有这些突变的患者更有可能出现白细胞计数升高且预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/73b9cde0f7a2/cancers-11-01311-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/31290049faaa/cancers-11-01311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/d5a9769dfe09/cancers-11-01311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/d6da80d0f8c8/cancers-11-01311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/cd030c66240f/cancers-11-01311-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/73b9cde0f7a2/cancers-11-01311-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/31290049faaa/cancers-11-01311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/d5a9769dfe09/cancers-11-01311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/d6da80d0f8c8/cancers-11-01311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/cd030c66240f/cancers-11-01311-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe7/6770268/73b9cde0f7a2/cancers-11-01311-g005a.jpg

相似文献

1
The Impact of Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis.基因突变在急性早幼粒细胞白血病中的影响:一项荟萃分析
Cancers (Basel). 2019 Sep 5;11(9):1311. doi: 10.3390/cancers11091311.
2
Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.伴有FLT3基因改变的急性早幼粒细胞白血病预后较差。
Leuk Lymphoma. 2006 Sep;47(9):1788-93. doi: 10.1080/10428190600687927.
3
Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia.FLT3-ITD突变对急性早幼粒细胞白血病化疗反应及预后的潜在影响
Cancer Manag Res. 2021 Mar 12;13:2371-2378. doi: 10.2147/CMAR.S297421. eCollection 2021.
4
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.长的 FLT3 内部串联重复和诊断时 PML-RARα 表达减少的特征是急性早幼粒细胞白血病患者的一个高危亚组。
Haematologica. 2010 May;95(5):745-51. doi: 10.3324/haematol.2009.015073. Epub 2010 Feb 4.
5
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.急性早幼粒细胞白血病(APL)患者中FLT3和Ras基因突变的预后意义:来自欧洲APL协作组的一项回顾性研究
Leukemia. 2005 Jul;19(7):1153-60. doi: 10.1038/sj.leu.2403790.
6
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.急性早幼粒细胞白血病中FLT3突变状态、生物学特征与靶向治疗反应之间的关系
Blood. 2005 Dec 1;106(12):3768-76. doi: 10.1182/blood-2005-04-1746. Epub 2005 Aug 16.
7
Prognostic significance of FLT3 ITD and D835 mutations in AML patients.FLT3内部串联重复(ITD)和D835突变在急性髓系白血病(AML)患者中的预后意义。
Hematol J. 2003;4(1):41-6. doi: 10.1038/sj.thj.6200224.
8
[Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].[急性早幼粒细胞白血病中FLT3突变的患病率及临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):757-61.
9
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol.急性早幼粒细胞白血病中FLT3基因的改变:与诊断特征的关联以及接受意大利AIDA方案治疗患者的临床结局分析
Leukemia. 2002 Nov;16(11):2185-9. doi: 10.1038/sj.leu.2402723.
10
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.全反式维甲酸和蒽环类单药化疗治疗急性早幼粒细胞白血病患者中 FLT3 突变的预后价值。
Haematologica. 2011 Oct;96(10):1470-7. doi: 10.3324/haematol.2011.044933. Epub 2011 Jun 17.

引用本文的文献

1
Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the CONS.高危急性早幼粒细胞白血病患者需要进行为期1年的维持治疗——CONS研究。
Haematologica. 2025 Jul 1;110(7):1459-1465. doi: 10.3324/haematol.2025.287418. Epub 2025 Apr 3.
2
Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them.现实世界中的急性早幼粒细胞白血病:理解结局差异以及我们如何改善这些差异。
Cancers (Basel). 2024 Dec 6;16(23):4092. doi: 10.3390/cancers16234092.
3
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.

本文引用的文献

1
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.急性早幼粒细胞白血病的治疗:欧洲白血病网专家小组的最新建议。
Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25.
2
FLT3 inhibitors in acute myeloid leukemia.FLT3 抑制剂在急性髓系白血病中的应用。
J Hematol Oncol. 2018 Dec 4;11(1):133. doi: 10.1186/s13045-018-0675-4.
3
FLT3 inhibitors in acute myeloid leukemia: Current and future.急性髓系白血病中的FLT3抑制剂:现状与未来。
全反式维甲酸、三氧化二砷和吉妥单抗奥唑米星治疗急性早幼粒细胞白血病的2期研究长期随访
Cancer. 2025 Jan 1;131(1):e35662. doi: 10.1002/cncr.35662. Epub 2024 Nov 25.
4
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature.家族性急性早幼粒细胞白血病:一例报告并文献复习
Onco Targets Ther. 2024 Sep 4;17:733-738. doi: 10.2147/OTT.S482781. eCollection 2024.
5
Acute promyelocytic leukemia in children cancer hospital Egypt.埃及儿童癌症医院的急性早幼粒细胞白血病
Discov Oncol. 2024 Jun 11;15(1):223. doi: 10.1007/s12672-024-01037-6.
6
Favorable outcome of short isoform and mutation in a patient with several adverse prognostic markers: A case report.一名具有多种不良预后标志物的患者出现短异构体和突变的良好结局:病例报告。
Clin Case Rep. 2023 Jul 6;11(7):e07637. doi: 10.1002/ccr3.7637. eCollection 2023 Jul.
7
Fatal intracranial haemorrhage in acute promyelocytic leukemia patients with short isoform of PML-RARα: Review of molecular and radiological data.急性早幼粒细胞白血病患者中PML-RARα短异构体导致的致命性颅内出血:分子与影像学数据综述
Saudi J Biol Sci. 2023 Jul;30(7):103710. doi: 10.1016/j.sjbs.2023.103710. Epub 2023 Jun 19.
8
Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases.伴有罕见遗传学异常的急性早幼粒细胞白血病:三例报告。
Genes (Basel). 2022 Dec 23;14(1):46. doi: 10.3390/genes14010046.
9
Association between and additional chromosomal abnormalities in the prognosis of acute promyelocytic leukemia.与急性早幼粒细胞白血病预后相关的额外染色体异常。
J Int Med Res. 2022 Dec;50(12):3000605221138490. doi: 10.1177/03000605221138490.
10
Case Report: Successful therapy with all- retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the fusion gene.病例报告:全反式维甲酸联合化疗继以造血干细胞移植成功治疗携带融合基因的急性早幼粒细胞白血病。
Front Oncol. 2022 Sep 23;12:1013046. doi: 10.3389/fonc.2022.1013046. eCollection 2022.
J Oncol Pharm Pract. 2019 Jan;25(1):163-171. doi: 10.1177/1078155218802620. Epub 2018 Sep 30.
4
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.三氧化二砷巩固治疗可降低急性早幼粒细胞白血病患儿蒽环类药物剂量:儿童肿瘤协作组III期历史对照试验AAML0631报告
J Clin Oncol. 2017 Sep 10;35(26):3021-3029. doi: 10.1200/JCO.2016.71.6183. Epub 2017 Aug 2.
5
Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways.三氧化二砷和全反式维甲酸通过共同抑制FLT3信号通路,对FLT3-ITD急性髓系白血病细胞选择性地发挥协同细胞毒性作用。
Leuk Lymphoma. 2017 Oct;58(10):2426-2438. doi: 10.1080/10428194.2017.1289522. Epub 2017 Mar 9.
6
FLT3-ITD Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand.泰国东北部急性髓系白血病患者中的FLT3-ITD突变
Asian Pac J Cancer Prev. 2016;17(9):4395-4399.
7
Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.FLT3-ITD阳性急性髓系白血病的预后:异基因干细胞移植和酪氨酸激酶抑制剂治疗的影响
J Cancer Res Clin Oncol. 2017 Feb;143(2):337-345. doi: 10.1007/s00432-016-2290-5. Epub 2016 Oct 24.
8
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.初诊急性早幼粒细胞白血病采用 ATRA 和 ATO 或 ATRA 和化疗治疗时的 PML-RARα 动力学和 FLT3-ITD 突变的影响。
Leukemia. 2016 Oct;30(10):1987-1992. doi: 10.1038/leu.2016.122. Epub 2016 May 2.
9
The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors.伴有不良预后因素的急性早幼粒细胞白血病患者外周血循环CD34+细胞水平较高。
Hematology. 2016 Oct;21(9):513-9. doi: 10.1080/10245332.2016.1150410. Epub 2016 Mar 31.
10
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy.接受基于三氧化二砷的一线治疗的新诊断急性早幼粒细胞白血病患者的预后因素
Leuk Res. 2015 Sep;39(9):938-44. doi: 10.1016/j.leukres.2015.05.016. Epub 2015 Jul 2.